Nate Silver @NateSilver538
This seems like good news on medium-term immunity, as it may be the first study that's followed patients for as long as it has (6 months). But of course it's not getting nearly as much media attention as those ¡AnTiBoDiEs FaDe AfTeR 3 MoNThS! headlines. https://t.co/aPUkPM0aqL https://t.co/p7Dv8oLyeo — PolitiTweet.org